{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:07:45Z","timestamp":1762506465381},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,12,14]],"date-time":"2014-12-14T00:00:00Z","timestamp":1418515200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s11102-014-0619-0","type":"journal-article","created":{"date-parts":[[2014,12,13]],"date-time":"2014-12-13T06:29:47Z","timestamp":1418452187000},"page":"217-224","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Current status on histological classification in Cushing\u2019s disease"],"prefix":"10.1007","volume":"18","author":[{"given":"Luis V.","family":"Syro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Rotondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Cusimano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Di Ieva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina M.","family":"Restrepo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald W.","family":"Killinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harley","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalman","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,14]]},"reference":[{"key":"619_CR1","first-page":"137","volume":"50","author":"H Cushing","year":"1932","unstructured":"Cushing H (1932) The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp 50:137\u2013195","journal-title":"Bull Johns Hopkins Hosp"},{"issue":"4","key":"619_CR2","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1210\/jc.2012-3200","volume":"98","author":"X Bertagna","year":"2013","unstructured":"Bertagna X, Guignat L (2013) Approach to the Cushing\u2019s disease patient with persistent\/recurrent hypercortisolism after pituitary surgery. J Clin Endocrinol Metab 98(4):1307\u20131318. doi: 10.1210\/jc.2012-3200","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"619_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cen.12345","volume":"80","author":"MR Gadelha","year":"2014","unstructured":"Gadelha MR, Vieira Neto L (2014) Efficacy of medical treatment in Cushing\u2019s disease: a systematic review. Clin Endocrinol 80(1):1\u201312. doi: 10.1111\/cen.12345","journal-title":"Clin Endocrinol"},{"issue":"1","key":"619_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-013-1151-1","volume":"114","author":"M Fleseriu","year":"2013","unstructured":"Fleseriu M, Petersenn S (2013) New avenues in the medical treatment of Cushing\u2019s disease: corticotroph tumor targeted therapy. J Neurooncol 114(1):1\u201311. doi: 10.1007\/s11060-013-1151-1","journal-title":"J Neurooncol"},{"issue":"2","key":"619_CR5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1210\/jc.2012-3126","volume":"98","author":"RA Feelders","year":"2013","unstructured":"Feelders RA, Hofland LJ (2013) Medical treatment of Cushing\u2019s disease. J Clin Endocrinol Metab 98(2):425\u2013438. doi: 10.1210\/jc.2012-3126","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"619_CR6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s11102-012-0397-5","volume":"15","author":"M Fleseriu","year":"2012","unstructured":"Fleseriu M, Petersenn S (2012) Medical management of Cushing\u2019s disease: what is the future? Pituitary 15(3):330\u2013341. doi: 10.1007\/s11102-012-0397-5","journal-title":"Pituitary"},{"issue":"2","key":"619_CR7","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1530\/JOE-14-0300","volume":"223","author":"D Cuevas-Ramos","year":"2014","unstructured":"Cuevas-Ramos D, Fleseriu M (2014) Treatment of Cushing\u2019s disease: a mechanistic update. J Endocrinol 223(2):R19\u2013R39. doi: 10.1530\/joe-14-0300","journal-title":"J Endocrinol"},{"issue":"4","key":"619_CR8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/MED.0b013e3283631809","volume":"20","author":"LK Nieman","year":"2013","unstructured":"Nieman LK (2013) Update in the medical therapy of Cushing\u2019s disease. Curr Opin Endocrinol Diabetes Obes 20(4):330\u2013334. doi: 10.1097\/MED.0b013e3283631809","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"3","key":"619_CR9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1053\/j.semdp.2013.06.002","volume":"30","author":"O Mete","year":"2013","unstructured":"Mete O, Asa SL (2013) Therapeutic implications of accurate classification of pituitary adenomas. Semin Diagn Pathol 30(3):158\u2013164. doi: 10.1053\/j.semdp.2013.06.002","journal-title":"Semin Diagn Pathol"},{"issue":"4","key":"619_CR10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1750-3639.2012.00599.x","volume":"22","author":"O Mete","year":"2012","unstructured":"Mete O, Asa SL (2012) Clinicopathological correlations in pituitary adenomas. Brain Pathol 22(4):443\u2013453. doi: 10.1111\/j.1750-3639.2012.00599.x","journal-title":"Brain Pathol"},{"key":"619_CR11","unstructured":"Asa SL (2011) Tumors of the pituitary Gland, vol. Fascicle 15, 4th Series. The Atlas of Tumor Pathology. Armed Forces Institute of Pathology, Washington, DC"},{"issue":"3","key":"619_CR12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00418-008-0472-1","volume":"130","author":"RY Osamura","year":"2008","unstructured":"Osamura RY, Kajiya H, Takei M, Egashira N, Tobita M, Takekoshi S, Teramoto A (2008) Pathology of the human pituitary adenomas. Histochem Cell Biol 130(3):495\u2013507. doi: 10.1007\/s00418-008-0472-1","journal-title":"Histochem Cell Biol"},{"issue":"4","key":"619_CR13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1586\/17446651.2014.922412","volume":"9","author":"LV Syro","year":"2014","unstructured":"Syro LV, Builes CE, Di Ieva A, Sav A, Rotondo F, Kovacs K (2014) Improving differential diagnosis of pituitary adenomas. Expert Rev Endocrinol Metab 9(4):377\u2013386. doi: 10.1586\/17446651.2014.922412","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"3","key":"619_CR14","doi-asserted-by":"crossref","first-page":"R223","DOI":"10.1530\/JME-14-0011","volume":"52","author":"D Cuevas-Ramos","year":"2014","unstructured":"Cuevas-Ramos D, Fleseriu M (2014) Somatostatin receptor ligands and resistance to treatment in pituitary adenomas. J Mol Endocrinol 52(3):R223\u2013R240. doi: 10.1530\/jme-14-0011","journal-title":"J Mol Endocrinol"},{"issue":"1","key":"619_CR15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.humpath.2013.08.007","volume":"45","author":"L Chinezu","year":"2014","unstructured":"Chinezu L, Vasiljevic A, Jouanneau E, Francois P, Borda A, Trouillas J, Raverot G (2014) Expression of somatostatin receptors, SSTR2A and SSTR5, in 108 endocrine pituitary tumors using immunohistochemical detection with new specific monoclonal antibodies. Hum Pathol 45(1):71\u201377. doi: 10.1016\/j.humpath.2013.08.007","journal-title":"Hum Pathol"},{"issue":"2","key":"619_CR16","doi-asserted-by":"crossref","first-page":"R69","DOI":"10.1530\/JME-12-0113","volume":"49","author":"O Mete","year":"2012","unstructured":"Mete O, Ezzat S, Asa SL (2012) Biomarkers of aggressive pituitary adenomas. J Mol Endocrinol 49(2):R69\u2013R78. doi: 10.1530\/jme-12-0113","journal-title":"J Mol Endocrinol"},{"issue":"11","key":"619_CR17","first-page":"4639","volume":"32","author":"A Sav","year":"2012","unstructured":"Sav A, Rotondo F, Syro LV, Scheithauer BW, Kovacs K (2012) Biomarkers of pituitary neoplasms. Anticancer Res 32(11):4639\u20134654","journal-title":"Anticancer Res"},{"issue":"4","key":"619_CR18","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1530\/EJE-09-0414","volume":"161","author":"A Takeshita","year":"2009","unstructured":"Takeshita A, Inoshita N, Taguchi M, Okuda C, Fukuhara N, Oyama K, Ohashi K, Sano T, Takeuchi Y, Yamada S (2009) High incidence of low O(6)-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing\u2019s disease. Eur J Endocrinol 161(4):553\u2013559. doi: 10.1530\/EJE-09-0414","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"619_CR19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1227\/NEU.0b013e318230ac63","volume":"70","author":"F Salehi","year":"2012","unstructured":"Salehi F, Scheithauer BW, Kovacs K, Horvath E, Syro LV, Sharma S, Manoranjan B, Cusimano M (2012) O-6-methylguanine-DNA methyltransferase (MGMT) immunohistochemical expression in pituitary corticotroph adenomas. Neurosurgery 70(2):491\u2013496. doi: 10.1227\/NEU.0b013e318230ac63 ; discussion 496","journal-title":"Neurosurgery"},{"issue":"2","key":"619_CR20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s11102-012-0406-8","volume":"16","author":"A McCormack","year":"2013","unstructured":"McCormack A, Kaplan W, Gill AJ, Little N, Cook R, Robinson B, Clifton-Bligh R (2013) MGMT expression and pituitary tumours: relationship to tumour biology. Pituitary 16(2):208\u2013219. doi: 10.1007\/s11102-012-0406-8","journal-title":"Pituitary"},{"issue":"10","key":"619_CR21","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1055\/s-0030-1253419","volume":"118","author":"H Bode","year":"2010","unstructured":"Bode H, Seiz M, Lammert A, Brockmann MA, Back W, Hammes HP, Thome C (2010) SOM230 (pasireotide) and temozolomide achieve sustained control of tumour progression and ACTH secretion in pituitary carcinoma with widespread metastases. Exp Clin Endocrinol Diabetes 118(10):760\u2013763. doi: 10.1055\/s-0030-1253419","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"4","key":"619_CR22","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s11102-009-0211-1","volume":"14","author":"MS Thearle","year":"2011","unstructured":"Thearle MS, Freda PU, Bruce JN, Isaacson SR, Lee Y, Fine RL (2011) Temozolomide (Temodar\u00ae) and capecitabine (Xeloda\u00ae) treatment of an aggressive corticotroph pituitary tumor. Pituitary 14(4):418\u2013424. doi: 10.1007\/s11102-009-0211-1","journal-title":"Pituitary"},{"issue":"4","key":"619_CR23","doi-asserted-by":"crossref","first-page":"E447","DOI":"10.1227\/NEU.0000000000000251","volume":"74","author":"BE Zacharia","year":"2014","unstructured":"Zacharia BE, Gulati AP, Bruce JN, Carminucci AS, Wardlaw SL, Siegelin M, Remotti H, Lignelli A, Fine RL (2014) High response rates and prolonged survival in patients with corticotroph pituitary tumors and refractory Cushing disease from capecitabine and temozolomide (CAPTEM): a case series. Neurosurgery 74(4):E447\u2013E455. doi: 10.1227\/neu.0000000000000251 ; discussion E455","journal-title":"Neurosurgery"},{"issue":"1","key":"619_CR24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00401-013-1084-y","volume":"126","author":"J Trouillas","year":"2013","unstructured":"Trouillas J, Roy P, Sturm N, Dantony E, Cortet-Rudelli C, Viennet G, Bonneville JF, Assaker R, Auger C, Brue T, Cornelius A, Dufour H, Jouanneau E, Francois P, Galland F, Mougel F, Chapuis F, Villeneuve L, Maurage CA, Figarella-Branger D, Raverot G, Barlier A, Bernier M, Bonnet F, Borson-Chazot F, Brassier G, Caulet-Maugendre S, Chabre O, Chanson P, Cottier JF, Delemer B, Delgrange E, Di Tommaso L, Eimer S, Gaillard S, Jan M, Girard JJ, Lapras V, Loiseau H, Passagia JG, Patey M, Penfornis A, Poirier JY, Perrin G, Tabarin A (2013) A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8\u00a0years post-operative follow-up. Acta Neuropathol 126(1):123\u2013135. doi: 10.1007\/s00401-013-1084-y","journal-title":"Acta Neuropathol"},{"key":"619_CR25","author":"G Raverot","year":"2014","unstructured":"Raverot G, Jouanneau E, Trouillas J (2014) Clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies. Eur J Endocrinol. doi: 10.1530\/eje-13-1031","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"619_CR26","first-page":"423","volume":"10","author":"A Ieva Di","year":"2014","unstructured":"Di Ieva A, Rotondo F, Syro LV, Cusimano MD, Kovacs K (2014) Aggressive pituitary adenomas\u2013diagnosis and emerging treatments. Nat Rev Endocrinol 10(7):423\u2013435. doi: 10.1038\/nrendo.2014.64","journal-title":"Endocrinology"},{"key":"619_CR27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/path.1700410215","volume":"41","author":"AC Crooke","year":"1935","unstructured":"Crooke AC (1935) A change in the basophil cells of the pituitary gland common to conditions which exhibit the syndrome attributed to basophil adenoma. J Pathol Bacteriol 41:339\u2013349","journal-title":"J Pathol Bacteriol"},{"issue":"10","key":"619_CR28","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/00000478-200310000-00005","volume":"27","author":"DH George","year":"2003","unstructured":"George DH, Scheithauer BW, Kovacs K, Horvath E, Young WF Jr, Lloyd RV, Meyer FB (2003) Crooke\u2019s cell adenoma of the pituitary: an aggressive variant of corticotroph adenoma. Am J Surg Pathol 27(10):1330\u20131336","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"619_CR29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1385\/EP:12:3:329","volume":"12","author":"DJ Holthouse","year":"2001","unstructured":"Holthouse DJ, Robbins PD, Kahler R, Knuckey N, Pullan P (2001) Corticotroph pituitary carcinoma: case report and literature review. Endocr Pathol 12(3):329\u2013341","journal-title":"Endocr Pathol"},{"issue":"12","key":"619_CR30","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1210\/jc.2011-2031","volume":"96","author":"AP Heaney","year":"2011","unstructured":"Heaney AP (2011) Pituitary carcinoma: difficult diagnosis and treatment. J Clin Endocrinol Metab 96(12):3649\u20133660. doi: 10.1210\/jc.2011-2031","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"619_CR31","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/cen.12343","volume":"80","author":"T Thynne","year":"2014","unstructured":"Thynne T, White GH, Burt MG (2014) Factitious Cushing\u2019s syndrome masquerading as Cushing\u2019s disease. Clin Endocrinol 80(3):328\u2013332. doi: 10.1111\/cen.12343","journal-title":"Clin Endocrinol"},{"issue":"8","key":"619_CR32","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1590\/S0004-27302007000800016","volume":"51","author":"DJ Romanholi","year":"2007","unstructured":"Romanholi DJ, Salgado LR (2007) Pseudo-Cushing states. Arquivos brasileiros de endocrinologia e metabologia 51(8):1303\u20131313","journal-title":"Arquivos brasileiros de endocrinologia e metabologia"},{"issue":"1","key":"619_CR33","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1746-1596-5-56","volume":"5","author":"S Shahani","year":"2010","unstructured":"Shahani S, Nudelman R, Nalini R, Kim H-S, Samson S (2010) Ectopic corticotropin-releasing hormone (CRH) syndrome from metastatic small cell carcinoma: a case report and review of the literature. Diagn Pathol 5(1):56","journal-title":"Diagn Pathol"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-014-0619-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-014-0619-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-014-0619-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T06:08:22Z","timestamp":1559369302000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-014-0619-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,14]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["619"],"URL":"https:\/\/doi.org\/10.1007\/s11102-014-0619-0","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,14]]}}}